liposomal annamycin (L-Annamycin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for liposomal annamycin (L-Annamycin), covering 2022-08-26 to 2022-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases [Phase 1, Phase 2]